ASKER.ST
ASKER.ST
SE0024171458
Asker Healthcare Group AB
Loading chart...

Company Profile

Asker Healthcare Group AB (publ) provides medical supplies, devices, and equipment and related solutions that support patient care. The company supplies and distributes fittings and equipment; veterinary equipment; surgical and diagnostic instruments; medical supplies and equipment for urology, ultrasound diagnostics, laser treatment, and regenerative medicine; medical equipment for operating rooms, polyclinics, and day surgeries; hygiene equipment; equipment and products for beauty clinics; defibrillators and wound care products. In addition, it develops and sells disposable medical supplies under the Evercare, Selefa, and Embra brands; distributes eye surgery products; and develops and sells products for time-management, communication, and cognition for schools, assistive technology centres, and other public services. Further, the company provides support and assistance to people needing wound, diabetes, and urological care; ostomy, urology, and rehab services; ambulance services; and products for physiotherapy practices, as well as supplies exercise and treatment equipment and measurement. Additionally, it sells and rents out various mobility aids and rehab products, such as pressure-relieving mattresses and cushions, as well as manufactures and distributes pressure care products. The company operates in Sweden, Norway, Finland, Estonia, Latvia, Lithuania, Netherlands, Belgium, Luxembourg, Denmark, the United Kingdom, Ireland, Germany, Austria, Switzerland, France, Slovakia, Czech Republic, and Poland. Asker Healthcare Group AB (publ) was founded in 2006 and is headquartered in Danderyd, Sweden.

Related stocks

ARJO-B.ST
ARJO-B.ST • Sweden
Arjo AB ser. B
27.18 SEK
740.74M USD 1Y -13.2%
AMP.MI
AMP.MI • Italy
AMPLIFON
12.86 EUR
3.83B USD 1Y -20.6%
UPR.IR
UPR.IR • Ireland
UNIPHAR PLC
3.84 EUR
1.12B USD 1Y +2.5%
GALE.SW
GALE.SW • Switzerland
GALENICA N
85.2 CHF
5.11B USD 1Y -4.1%
0874.HK
0874.HK • China
BAIYUNSHAN PH
13.21 HKD
2.74B USD 1Y -27.9%
008930.KS
008930.KS • South Korea
Hanmi Science
54,900 KRW
2.78B USD 1Y +44.1%
600739.SS
600739.SS • China
LIAONING CHENGDA
10.33 CNY
2.35B USD 1Y -17%
600511.SS
600511.SS • China
CHINA NATIONAL MEDICINES CORP
26.67 CNY
3.01B USD 1Y -7.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
-
Max Drawdown (3Y)
-
Sharpe Ratio (3Y)
-
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
ende